You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股暗盤 | 和鉑醫藥-B(2142.HK)暗盤段漲9.7%
格隆匯 12-09 16:24
格隆匯12月9日丨據輝立證券,和鉑醫藥-B(2142.HK)暗盤段現報13.58港元,較發行價12.38港元漲9.69%。公司是一家臨牀階段生物製藥企業,從事研究及開發免疫與腫瘤疾病領域的差異化抗體療法,2018年、2019年收益分別為148.3萬、541.9萬美元,每股有形資產淨值3.00-3.21港元。此次上市全球發售約1.38億股,其中香港公開發售5529萬股,國際發售8293.1萬股,每手1000股,一手中籤率10%,香港公開發售獲78.54倍認購,淨籌15.988億港元。高瓴資本、Black Rock Funds等多家基石投資者已認購合共5761.2萬股,相當於緊隨全球發售完成後公司已發行股本約7.5%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account